Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B6 for Tardive Dyskinesia in Schizophrenia
NCT01908452Phase 3Withdrawn
- Sponsor
- Be'er Sheva Mental Health Center
- Start
- Jul 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pyridoxine in tardive dyskinesia (TD), sponsored by Be'er Sheva Mental Health Center. Planned start Jul 2011; status: withdrawn.
02
Drugs
pyridoxine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT01908452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908452.